PRI's Focus on Health Care
View this email in your browser ([link removed])
[link removed]
Nothing Curative About Dems Inflation, Higher Taxes and Prices
Newsmax | Sally Pipes
July 7, 2022
Congressional Democrats are one step closer to passing their trillion-dollar “Build Back Better” spending package.
On July 6 U.S. Senate leaders hashed out ([link removed]) a key proposal that would allow Medicare to “negotiate” with pharmaceutical companies over prescription drug prices.
Read more. . . ([link removed])
Wayne Winegarden Plan to Let Medicare Negotiate Drug Prices on Scripps National News
Scripps National News | Wayne Winegarden
July 7, 2022
In a national TV interview with Scripps National News, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, says making drug rebates work for patients would more effectively lower patient costs compared to a plan working its way through Congress to let Medicare negotiate prescription drug prices.
Watch here . . . ([link removed])
Centennial State About to Discover Public Option's Nightmare
Newsmax | Sally Pipes
July 5, 2022
Colorado is about to become the first state to implement a public health insurance option through Section 1332, a provision in Obamacare that allows states to waive many of the law’s regulations.
The Biden administration approved the program ([link removed]) , known as the Colorado Option, on June 23.
Read more. . . ([link removed])
New price transparency rule will help patients
Washington Examiner | Sally Pipes
July 11, 2022
This month, a federal rule requiring certain private health plans ([link removed]) to disclose the rates they pay providers for covered healthcare services takes effect. The Trump-era regulation, ([link removed]) along with a similar rule requiring hospitals to publish their prices, is an example of the previous administration’s drive to make the healthcare system more transparent.
Read more. . . ([link removed])
============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2022 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
P.O. Box 60485 | Pasadena, CA 91116
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
